Clinical trial

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

NCT00318474 · St. Joseph's Hospital and Medical Center, Phoenix, Other · Terminated

Key facts

NCT number NCT00318474
Title Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
Official title A Randomized Controlled Trial of Mycophenolate Mofetil in Patients With IgA Nephropathy
Lead sponsor St. Joseph's Hospital and Medical Center, Phoenix, Other
Status Terminated
Phase Phase 3
Study type Interventional
Conditions IgA Nephropathy
Intervention type Drug
Interventions Mycophenolate Mofetil (MMF), MMF Placebo, ACEi, FOS
Enrollment 184
Start date Jan 1, 2002
Primary completion Mar 1, 2008
Completion Mar 1, 2010
First posted Apr 26, 2006
Last update posted Mar 7, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies